Bio-Rad Laboratories, Inc., a leading global provider of life science research and clinical diagnostics products, is headquartered in the United States. Founded in 1952, the company has established itself as a key player in the biotechnology industry, with significant operations across North America, Europe, and Asia. Bio-Rad's core offerings include a diverse range of products such as reagents, instruments, and software for research and clinical applications. Their innovative solutions, particularly in the fields of genomics, proteomics, and quality control, set them apart in a competitive market. Notably, Bio-Rad has achieved recognition for its commitment to advancing scientific discovery and improving healthcare outcomes. With a strong market position, Bio-Rad continues to drive progress in the life sciences sector, underscoring its role as a trusted partner for researchers and clinicians worldwide.
How does Bio Rad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bio Rad's score of 34 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Bio-Rad Laboratories, Inc. reported total carbon emissions of approximately 295,930,000 kg CO2e across all scopes. This includes about 21,216,000 kg CO2e from Scope 1 emissions, 16,813,000 kg CO2e from Scope 2 (market-based), and a significant 295,930,000 kg CO2e from Scope 3 emissions, which encompasses categories such as purchased goods and services (approximately 250,135,000 kg CO2e) and business travel (about 7,098,000 kg CO2e). Bio-Rad has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 carbon emissions by 46% from a 2019 baseline by the year 2030. This target reflects a commitment to significant emissions reductions in the near term, with a specific goal of achieving a 46.2% reduction by 2030, as outlined in their sustainability reports. The company’s emissions data is not cascaded from any parent organization, indicating that these figures are independently reported by Bio-Rad Laboratories, Inc. This commitment to transparency and accountability in emissions reporting aligns with industry standards and reflects Bio-Rad's dedication to addressing climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 18,420,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 13,615,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 314,454,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Bio Rad's Scope 3 emissions, which decreased by 26% last year and decreased by approximately 6% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bio Rad has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
